quin2 has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (81.25) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aktories, K; Grimminger, F; Just, I; Seeger, W; Sibelius, U | 1 |
| Avdonin, PV; Cheglakov, IB; Tkachuk, VA | 1 |
| Northover, AM | 1 |
| Hallam, TJ; Rink, TJ | 1 |
| Rink, TJ; Sage, SO | 1 |
| Hardisty, RM; Pannocchia, A | 1 |
| Becker, EL; Molski, MM; Naccache, PH; Sha'afi, RI; Volpi, M | 1 |
| Bushfield, M; MacIntyre, DE; Shaw, AM | 1 |
| Bushfield, M; MacIntyre, DE; MacMillan, LJ; McNicol, A; Pollock, WK; Shaw, AM | 1 |
| Baroggi, N; Braquet, P; Etienne, A | 1 |
| Hallam, TJ; Rink, TJ; Simpson, AW | 1 |
| Andries, R; Baroggi, N; Bourgain, R; Braquet, P; Clostre, F; Esanu, A; Etienne, A | 1 |
| Braquet, P; Chap, H; Douste-Blazy, L; Simon, MF | 1 |
| Hardisty, RM; Powling, MJ | 1 |
| Johnson, B; Valone, FH | 1 |
| Daniel, JL; Hallam, TJ; Kendrick-Jones, J; Rink, TJ | 1 |
16 other study(ies) available for quin2 and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Suppression of cytoskeletal rearrangement in activated human neutrophils by botulinum C2 toxin. Impact on cellular signal transduction.
Topics: Actins; Aminoquinolines; Botulinum Toxins; Calcium; Cytoskeleton; Diglycerides; Fluorescent Dyes; Humans; Inositol Phosphates; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphatidylinositols; Platelet Activating Factor; Polymers; Signal Transduction; Superoxides | 1991 |
Stimulation of non-selective cation channels providing Ca2+ influx into platelets by platelet-activating factor and other aggregation inducers.
Topics: Aminoquinolines; Barium; Biological Transport; Blood Platelets; Calcium; Cations; Fluorescent Dyes; Ion Channels; Membrane Potentials; Platelet Activating Factor; Platelet Aggregation | 1991 |
Modification by some antagonists of the shape changes of venous endothelial cells in response to inflammatory agents in vitro.
Topics: Aminoquinolines; Animals; Bradykinin; Calcimycin; Calcium; Cimetidine; Endothelium, Vascular; Guinea Pigs; Histamine; Histamine Antagonists; Isoproterenol; Platelet Activating Factor; Pyrilamine; Vena Cava, Inferior | 1990 |
Agonists stimulate divalent cation channels in the plasma membrane of human platelets.
Topics: Adenosine Diphosphate; Aminoquinolines; Blood Platelets; Calcium; Cations, Divalent; Cell Membrane; Egtazic Acid; Fluorescent Dyes; Humans; Ion Channels; Kinetics; Manganese; Pentetic Acid; Platelet Activating Factor; Thrombin | 1985 |
Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2-loaded human platelets.
Topics: 1-Methyl-3-isobutylxanthine; Aminoquinolines; Blood Platelets; Calcium; Colforsin; Cyclic AMP; Cytosol; Diterpenes; Fluorescent Dyes; Humans; Platelet Activating Factor; Platelet Aggregation; Thrombin | 1985 |
Cyclic AMP inhibits platelet activation independently of its effect on cytosolic free calcium.
Topics: Adenosine Diphosphate; Aminoquinolines; Blood Platelets; Bucladesine; Calcimycin; Calcium; Cyclic AMP; Cytosol; Epoprostenol; Humans; Platelet Activating Factor; Thrombin | 1985 |
Unique inhibitory profile of platelet activating factor induced calcium mobilization, polyphosphoinositide turnover and granule enzyme secretion in rabbit neutrophils towards pertussis toxin and phorbol ester.
Topics: Aminoquinolines; Animals; Bacterial Toxins; Calcium; Cytoplasmic Granules; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pertussis Toxin; Phorbols; Phosphatidic Acids; Phosphatidylinositol Phosphates; Phosphatidylinositols; Platelet Activating Factor; Rabbits; Tetradecanoylphorbol Acetate; Type C Phospholipases; Virulence Factors, Bordetella | 1985 |
Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase C.
Topics: Aminoquinolines; Blood Platelets; Calcium; Cyclic AMP; Cyclic GMP; Cytosol; Diglycerides; Fluorescent Dyes; Humans; In Vitro Techniques; Platelet Activating Factor; Protein Kinase C; Protein Kinases; Spectrometry, Fluorescence | 1985 |
Endogenous and pharmacological mechanisms for the regulation of human platelet cytosolic free Ca2+.
Topics: Aminoquinolines; Blood Platelets; Calcium; Calcium Channel Blockers; Cytosol; Egtazic Acid; Fluorescent Dyes; Homeostasis; Humans; Kinetics; Phosphatidylinositols; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Prostaglandins, Synthetic; Thromboxanes | 1985 |
Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Topics: Aminoquinolines; Animals; Blood Platelets; Calcium; Cytosol; Diterpenes; Dose-Response Relationship, Drug; Ginkgolides; Lactones; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Spectrometry, Fluorescence; Structure-Activity Relationship | 1986 |
Low concentrations of the stable prostaglandin endoperoxide U44069 stimulate shape change in quin2-loaded platelets without a measurable increase in [Ca2+]i.
Topics: Aminoquinolines; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Egtazic Acid; Fluorescent Dyes; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Spectrometry, Fluorescence | 1986 |
Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties.
Topics: Administration, Oral; Aminoquinolines; Animals; Aorta; Benzazepines; Blood Platelets; Calcium; Calcium Channel Blockers; Cytoplasm; Fibrinolytic Agents; Guinea Pigs; Injections, Intravenous; Male; Muscle Contraction; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Thrombosis | 1986 |
Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
Topics: Aminoquinolines; Blood Platelets; Calcium; Diterpenes; Dose-Response Relationship, Drug; Enzyme Activation; Ginkgolides; Humans; Lactones; Phosphatidic Acids; Phosphorus Radioisotopes; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Type C Phospholipases | 1987 |
Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+.
Topics: Adenosine Triphosphate; Aminoquinolines; Blood Platelets; Calcium; Cytosol; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Tetradecanoylphorbol Acetate; Thrombin; Vasopressins | 1986 |
Decay of the activating signal after platelet stimulation with 1-0-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine: changes in calcium permeability.
Topics: Adult; Aminoquinolines; Blood Platelets; Calcium; Cell Membrane Permeability; Fluorescent Dyes; Humans; Kinetics; Platelet Activating Factor | 1985 |
Relationship between cytoplasmic free calcium and myosin light chain phosphorylation in intact platelets.
Topics: Aminoquinolines; Blood Platelets; Calcium; Cytoplasm; Electrophoresis, Polyacrylamide Gel; Ethers; Fluorescent Dyes; Humans; Ionomycin; Ionophores; Myosins; Phosphorylation; Platelet Activating Factor | 1985 |